Tag Archives: They

Roche, Novartis are revving up next-generation eye drugs, but are they true contenders?

Roche and Novartis are working hard on next-generation drugs for wet age-related macular degeneration, and they’re hoping to steal significant market share away from entrenched drugs. But analysts aren’t convinced the new candidates can do the job. The Swiss pharma giants each rolled out data over the weekend backing their candidates—faricimab from Roche and brolucizumab… Read More »

Are supplements safe and do they work?

The story of a man who ended up needing a liver transplant after taking green tea capsules has brought the topic of dietary supplements back into the news. What are some of the dangers of supplements and what are the health benefits? When Jim McCants started taking green tea pills he had hoped he was… Read More »